Investment Options To Consider: NII Holdings Inc(NASDAQ:NIHD), Nanosphere, Inc.(NASDAQ:NSPH), and Provectus Biopharmaceuticals Inc(NYSEMKT:PVCT)

Posted by admin September 9, 2014 0 Comment 564 views


New York, NY – 09/09/2014 –  HotStockGains provides investors  and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.

NII Holdings Inc(NASDAQ:NIHD) gained $0.062 to reach a new closing price of $0.172, a 56.64% increase in value from the previous closing price. The stock has nevertheless seen its value significantly decline since the Virginia-based company lost fifty cents on Aug. 12th. NII Holdings Inc(NASDAQ:NIHD) has seen its trading volume spike to a figure of 17,333,998. The company currently has a bid price of $0.15 x 8,000 and has traded within a range of $0.11 to $7.50 over the past 52 weeks.

Will NII Holdings Recover? Click Here For A Free NIHD Analysis.

Nanosphere, Inc.(NASDAQ:NSPH) enjoyed an 11.27% increase in value yesterday as the stock gained $0.063 to move to a new closing price of $0.62. The stock nevertheless remains just eight cents above its 52 week low of $0.54. To contrast, the stock is now sitauted $2.35 below its 52 week high of $2.97. Nanosphere, Inc.(NASDAQ:NSPH) currently has a bid price of $0.40 x 100 and $0.75 x 5,000. On Sunday, the Illinois-based company presented data on the economic impact its BC-GP rapid sepsis diagnostic testing at the Interscience Conference on Antimicrobial Agents and Chemotherapy.

Is Now The Time To Invest In Nanosphere? View Our Free NSPH Analysis.

Provectus Biopharmaceuticals Inc(NYSEMKT:PVCT) saw its value increase by 6.67% yesterday as the stock gained seven cents to reach a new closing price of $1.12. The stock has closed within a range of $0.84 to $1.29 over the past three months. Provectus Biopharmaceuticals Inc(NYSEMKT:PVCT), which currently has a bid price of $1.04 x 1,000 and an ask price of $1.25 x 5,000, develops pharmaceuticals for oncology and dermatology indications. The Tennessee-based company has a market capitaliation of $185.47 million.

What Does The Future Hold For Provectus Biopharmaceuticals Inc? Read Our Free PVCT Report.

About HotStockGains

I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.

I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.

Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.


Write Your Comment